switching from tirzepatide to semaglutide for maintenance How Safely Transition To Switching Between Semaglutide and Tirzepatide:

Still, as use of GLP-1 medication continues to grow across Houston and beyond, Worley and Jakobi said the findings offer encouraging insights for patients and providers alike

In 2025, the company delivered a strong +9.95% YoY revenue growth, supported by key brands: Prolia ($4.41B) continues to lead in bone health with sustained demand, Repatha ($3.01B) is gaining momentum driven by broader adoption in cardiovascular risk management, and Otezla ($2.26B) remains a steady contributor in inflammation despite increasing competition, highlighting a well-balanced growth portfolio

McMullen says that because consumers dont know what they are taking, the risks are incredibly broad

Now, statistically, you know, the increased risk is so small its a small risk in an absolute sense, and a study like this doesnt prove causation, but obviously the magnitude of the risk from the behavior, suicide, is monumental

In Handbook of Diet and Nutrition in the Menstrual Cycle, Periconception and Fertility 431448 (Brill | Wageningen Academic, 2014)